NEW YORK (GenomeWeb News) — MDS this week filed with the Toronto Stock Exchange to buy back up to 4.5 million of its common shares over the next 12 months.
 
The potential buyback relates to MDS’ shares that trade on the Toronto exchange and will not affect the company’s shares that trade on the New York Stock Exchange.
 
As of June 26, MDS had 122.5 million shares issued and outstanding on the Toronto Stock Exchange.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.